HAEMONETICS CORP — Director's Dealing 2018

Sep 12, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HAEMONETICS CORP (HAE)
CIK: 0000313143
Period of Report: 2018-09-10

Reporting Person: Scanlan Jacqueline (SVP, Global Human Resources)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-09-10	Common Stock	M	1299	$38.43	Acquired	7552	Direct
2018-09-10	Common Stock	S	1299	$112.19	Disposed	6253	Direct
2018-09-10	Common Stock	M	2889	$41.64	Acquired	9142	Direct
2018-09-10	Common Stock	S	2889	$112.19	Disposed	6253	Direct
2018-09-10	Common Stock	S	702	$112.19	Disposed	5551	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-09-10	Non-qualified Stock Option (Right to Buy)	$38.43	M	1299	Disposed	2024-03-06	Common Stock (1299)	Direct
2018-09-10	Non-qualified Stock Option (Right to Buy)	$41.64	M	2889	Disposed	2024-06-06	Common Stock (2889)	Direct

Footnotes

F1: Transaction pursuant to an existing 10b5-1 trading plan.

F2: This number includes unvested restricted stock units previously reported.

F3: Grant to reporting person of right to buy shares of common stock exercisable in annual increments of 25 percent beginning on the first anniversary of the date of grant.